STAT3 and nonpapillary renal cell carcinoma: To further evaluate the role of NF-κB/STAT3-mediated G6PD overexpression in ccRCC growth, the MTS assay was conducted to determine the proliferation rate of ACHN and 786-O cells following treatment with STATTIC or BAY11-7082, respectively.